On April 3, 2017, CMS issued final updates to the Medicare Advantage and Part D Prescription Drug programs for 2018 in its Rate Announcement and Call Letter. On average, a 0.45% rate increase is expected for Medicare Advantage and Part D plans in 2018, which was a marginal increase from the .25% rate increase that was proposed in the February Advanced Notice and Draft Call Letter. Plans can expect a total estimated change of 2.95% in revenue when accounting for the expected growth in coding trend. Also, CMS said it will continue to use the bid-to-benchmark ratios used for 2017 payment to calculate MA Employer Group Waiver Plans (EGWPs) payments for 2018.